BioSpace News Archive

New Japanese Patent Further Strengthens Intellectual Property Portfolio Covering Company’s Novel Platform for Precisely Controlling Core Cell Migration Mechanisms

Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the appointment of Sheena K. Aurora, MD, as Vice President of Medical Affairs – Migraine Franchise.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is happy to provide the investment community with a review of the many challenges overcome and accomplishments achieved in 2019, with a vision for revenue and growth in 2020 by Generex President & CEO Joseph Moscato.

MedCerts, one of the nation’s leading providers of online career certification training, announces today the addition of Kelly Hover, former University of Phoenix Director, to its executive team.

The National Organization for Rare Disorders (NORD)®, the leading independent nonprofit organization representing over 25 million Americans living with rare diseases, is issuing a Rare Disease Day decree: Show Your Stripes!

UH partnered with GOJO on the study that eliminated influenza, MRSA and VRE through an Infection Risk Reduction Program

FDA working with manufacturer to assess scope of potential contamination risk, possible supply chain disruptions

The conference discusses caring for patients with gastrointestinal cancers using emerging treatment options

This is the first contract with this health plan that provides coverage for the PLA.

MedX Health Corp., dedicated to the early detection of skin cancer, announces that a total of 5,990,000 stock options have been granted to directors, Officers and employees and consultants.